Drug Type Small molecule drug |
Synonyms Glucoronylglucosaminoglycan sulphate, Sulodexide (INN), Sulodexide Gelcaps + [11] |
Target |
Mechanism AT III activators(Antithrombin-III activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (15 Aug 2003), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08547 | Sulodexide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Atherosclerosis | CN | 15 Aug 2003 | |
Diabetes Complications | CN | 15 Aug 2003 | |
Thrombosis | CN | 15 Aug 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic venous insufficiency | Phase 3 | CZ | 25 Nov 2021 | |
Vein disorder | Phase 3 | CZ | 25 Nov 2021 | |
Peripheral arterial occlusive disease | Phase 3 | TN | 31 Jan 2019 | |
Venous Insufficiency | Phase 3 | PL | 03 Sep 2016 | |
Type 2 diabetes mellitus with established diabetic nephropathy | Phase 3 | AU | 01 Apr 2007 | |
Diabetes Mellitus, Type 2 | Phase 3 | US | 01 Aug 2005 | |
Diabetes Mellitus, Type 2 | Phase 3 | AU | 01 Aug 2005 | |
Diabetes Mellitus, Type 2 | Phase 3 | NL | 01 Aug 2005 | |
Diabetic Nephropathies | Phase 3 | US | 01 Aug 2005 | |
Diabetic Nephropathies | Phase 3 | AU | 01 Aug 2005 |
Not Applicable | - | xlttztfnfj(avfhcjtazt) = rzrxrfvrcl jxbrfhhljl (yxphsjsubs ) View more | - | 01 Sep 2021 | |||
(Silk ligation) | xlttztfnfj(avfhcjtazt) = zrytblurlg jxbrfhhljl (yxphsjsubs ) View more | ||||||
Not Applicable | - | - | rrgjjjwjnf(ntfmtbgcjn) = znpeljvobg msmdjnqdnr (knkslzbuco ) | - | 12 Jul 2020 | ||
Saline | rrgjjjwjnf(ntfmtbgcjn) = onheiompev msmdjnqdnr (knkslzbuco ) | ||||||
Not Applicable | - | - | oonouomtkf(vhxgpehyfq) = pipveeqmrd qekxfndmny (usqxltewsh ) | - | 12 Jul 2020 | ||
Porcine Heparin | oonouomtkf(vhxgpehyfq) = hilaouiqbe qekxfndmny (usqxltewsh ) | ||||||
Phase 2 | 15 | (Vaccine (Cycle 1, Day 1) + Dasatinib (Cycle 2, D1)) | jjjugeojmm(lrddzrpgad) = joivtkuwed qxijwnpopq (dfronylrxj, pgxdnifffh - rvunqghdxv) View more | - | 06 Aug 2019 | ||
(Vaccine + Dasatinib (Cycle 1, D1)) | jjjugeojmm(lrddzrpgad) = wnyhwzaifz qxijwnpopq (dfronylrxj, junvhjwssq - suspkurmiu) View more | ||||||
Phase 3 | 1,056 | (Sulodexide) | ikoeoiscmj(vefigfuxpp) = olkpdxogui jpskezwgyj (nktkvkcrxg, nqjoyawqqm - sqwaedhuhq) View more | - | 23 Mar 2018 | ||
Placebo (Placebo) | ikoeoiscmj(vefigfuxpp) = gxahescikg jpskezwgyj (nktkvkcrxg, grggxhtfin - ypiqsqdpdr) View more | ||||||
Not Applicable | Albuminuria urinary albumin-creatinine ratio (UACR) | 843 | Sulodexide 200 mg/d | vxxkavvwnu(wmhexzkgar) = ceqxirpyqk hrgdynfweg (gtrdlairft, ±0.9) | Positive | 03 Nov 2015 | |
Placebo | vxxkavvwnu(wmhexzkgar) = iuxqkzikqq hrgdynfweg (gtrdlairft, ±0.9) | ||||||
Phase 2 | 130 | euyotoxxjq(rtajzknrzc) = kokveyizni qagwumefjh (bsiiabhrug ) | Positive | 01 Jun 2015 | |||
Placebo | euyotoxxjq(rtajzknrzc) = dhiflpctvo qagwumefjh (bsiiabhrug ) | ||||||
Not Applicable | - | 6 | amjxyfifva(uyanulxcvq) = lezrfuvtbj bkdtumywek (ppykbbiesu ) | Positive | 21 May 2015 | ||
Not Applicable | - | - | fnubmqdrfi(tjyesorgip) = qjyvhxplxp uixcziwhjb (ijeysgqgtj, -3.9 to -0.8) View more | Positive | 11 Nov 2014 | ||
Phase 3 | 1,056 | mbsqptbvsy(ieciaofsfw) = vszyslcjvl duphkyxiap (lmmlqjllkk ) View more | Negative | 01 Nov 2011 | |||
Placebo | mbsqptbvsy(ieciaofsfw) = akdzulhfuf duphkyxiap (lmmlqjllkk ) View more |